email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
181 - 195
of 3615 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Avistone Biotech Approved to Launch c-Met Inhibitor for NSCLC with Mutations
$5.00
Available
Gritgen’s Gene Therapy for Hemophilia 100% Effective in IIT Trial
$5.00
Available
ChromX Forms Diagnostic Collaboration with Boehringer Ingelheim for Lung Fibrosis
$5.00
Available
AriBio of South Korea Expands Phase III Trial of Alzheimer’s Therapy
$5.00
Available
Nona Collaborates with GeneQuantum to Offer Bioconjugate CMO Discovery Services
$5.00
Available
Viatris and Theravance Report COPD Therapy Effective in China Phase III Trial
$5.00
Available
Legend Signs $1.2 Billion Agreement Selling Global DLL3 CAR-T Rights to Novartis
$5.00
Available
AnchorDx and DiaCarta Team Up to Develop Early Cancer Screening Diagnostics
$5.00
Available
Sirius Files for Australian Trials of siRNA for Thromboembolic Disorders
$5.00
Available
Eccogene Signs $2 Billion Deal Selling Rights for GLP-1 Agonist to AstraZeneca
$5.00
Available
Porton Partners with BioMap for AI Based Gene Therapy Development
$5.00
Available
Lerna Biopharma to Present New siRNA Therapy for Liver Failure
$5.00
Available
WuXi XDC, an ADC/Bioconjugates CRDMO, Stages $500 Million IPO
$5.00
Available
Celest Therapeutics Acquires Novel CAR-NK Cell Therapy from Senti Bio in $156 Million Deal
$5.00
Available
Chipscreen Approved to Start China Trials for Novel Oral Psoriasis Therapy
$5.00
Available